← FDA DRUG APPROVALS

FDA NDA · NDA022220

TRIVARIS

Sponsor: ALLERGAN

APPLICATION
NDA022220
TYPE
NDA
ORIGINAL APPROVAL
2008-06-16
LATEST ACTION
2008-06-16
ROUTE
INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

TRIVARIS · ReferenceDiscontinued
TRIAMCINOLONE ACETONIDE 8MG/0.1ML (8MG/0.1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL

Approval history

2008-06-16Type 3 - New Dosage Form · Original · standard — Summary Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →